FINWIRES · TerminalLIVE
FINWIRES

Bridgebio Pharma Insider Sold Shares Worth $3,727,251, According to a Recent SEC Filing

By

Neil Kumar, Director, Chief Executive Officer, on August 18, 2026, sold 44,980 shares in Bridgebio Pharma (BBIO) for $3,727,251. Following the Form 4 filing with the SEC, Kumar has control over a total of 5,067,460 common shares of the company, with 243,327 shares held directly and 4,824,133 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000147083126000848/xslF345X05/wk-form4_1787257884.xml

Related Articles